Rasmus Jorgensen

Rasmus Jorgensen, PhD, currently serves as a Board Member at Ellegaard Göttingen Minipigs since August 2019 and is the CEO and Founder of Cytoki Pharma since January 2019. Previously, Rasmus held multiple Vice Presidential roles at Novo Nordisk from February 2008 to January 2019, overseeing various areas including GLP-1 & T2D Research, Diabetes and Cardiovascular Disease, and Diabetes Research in China. Rasmus's earlier experience includes positions at 7TM Pharma A/S as a Scientist and at 7TM Pharma as a project manager, along with a graduate student role at the University of Copenhagen, focusing on G-protein coupled receptor signaling. Educational qualifications include an Advanced Management Program from MIT Sloan School of Management, a PhD in Molecular Pharmacology from the University of Copenhagen, and a Master of Science in Biochemistry and Molecular Biology from Aarhus University.